Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Consort diagram of patient eligibility, Lauren classification subtype and receipt of adjuvant chemotherapy.

More »

Fig 1 Expand

Table 1.

Description of patients by Lauren classification subtype.

More »

Table 1 Expand

Table 2.

Description of patients by receipt of adjuvant chemotherapy.

More »

Table 2 Expand

Fig 2.

Kaplan-Meier estimates of relapse free survival among patients eligible for adjuvant therapy after curative resection of gastric cancer.

(A) By Lauren classification subtype. (B) By receipt of adjuvant chemotherapy in all patients. (C) By receipt of adjuvant chemotherapy in patients with intestinal gastric cancer only. (D) By receipt of adjuvant chemotherapy in patients with diffuse gastric cancer only.

More »

Fig 2 Expand

Table 3.

Relapse free survival by receipt of adjuvant chemotherapy.

More »

Table 3 Expand

Fig 3.

Histograms depicting time to relapse in months in patients who received adjuvant chemotherapy.

(A) All patients. (B) Diffuse gastric cancer patients only. (C) Intestinal gastric cancer patients only. (D) Mixed gastric cancer patients only. (E) Patients with adenocarcinoma not otherwise specified only.

More »

Fig 3 Expand